Europe’s EMA And Japan’s PMDA Forge Closer Links On Orphan Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
The European Medicines Agency and Japan’s Pharmaceutical and Medical Devices Agency have agreed to share information on the regulatory environment for orphan drugs. The cooperation is aimed at reducing bureaucracy for small- to medium-sized enterprises and improving the authorization process.